Validity was evaluated at baseline via known-groups defined using first and third quartiles of patients ' Disease Activity Score 28 based on C-reactive protein ( DAS28 ( CRP ) ) , Health Assessment Questionnaire-Disability Index ( HAQ-DI ) , Short Form-36 ( SF-36 ) items and PsA Quality of Life ( PsAQoL ) scores .